From John: White City News Maintenance via @WhiteCityNews

WhiteCityNews will be down for maintenance starting August 28th. We will be back after the Labor day holiday.

From John: White City News Maintenance via @WhiteCityNews

WhiteCityNews will be down for maintenance starting August 28th. We will be back after the Labor day holiday.

Marathon Pharmaceuticals continues to grow, adding new head of manufacturing

Marathon Pharmaceuticals continues to grow, adding new head of manufacturing via @WhiteCityNews

CHICAGO_3

Marathon Pharmaceuticals, LLC today announced Dave Bradshaw has joined the company as executive director of manufacturing. In this role, Bradshaw will oversee the manufacturing and supply operations for Marathon Pharmaceuticals’ rapidly growing portfolio of treatments.

(more…)

View On WordPress

ARCH Venture Partners builds massive $400M fund

ARCH Venture Partners builds massive $400M fund via @WhiteCityNews

venture-capital-feature-2wdk2kfp0bd1nyo8j9y4g0

ARCH Venture Partners, one of the largest U.S. technology venture firms investing in the development of seed and early-stage advanced technology companies, today announced that its eighth venture fund closed with more than $400 million in subscriptions. ARCH Venture Fund VIII exceeded its $250 million subscription target by more than $150 million.

(more…)

View On WordPress

Steve Blank’s advice on what it takes to be a life sciences lean startup

Steve Blank’s advice on what it takes to be a life sciences lean startup via @WhiteCityNews

steve-blank

Originally posted on MedCity News by 

What’s the difference between an extrovert and introvert in the world of principal investigators? Answer: Are they staring at your shoes or their shoes? The joke Steve Blank told during a fireside chat hosted by NYCBio illustrates the uphill challenge SBIR grant applicants face when they’re asked to break away from the insulated world of the…

View On WordPress

FDA simplifies process for novel medical devices

FDA simplifies process for novel medical devices

FDA-900x476

Truly innovative devices that do not have a “substantially equivalent” predecessor are automatically lumped into Class III, reserved for high-risk devices, and need a costly clinical trial to gain approval. But not all new products are high risk. To fix this barrier to innovation, FDA created the de novo approval pathway in 1997, enabling applicants to apply for approval as low- or moderate-risk…

View On WordPress

Medtronic snags FDA approval for next-generation pacemaker

Medtronic snags FDA approval for next-generation pacemaker via @WhiteCityNews

doctors-internet

Medtronic ($MDT) snagged FDA approval for its next-generation cardiac resynchronization therapy (CRT) pacemaker in patients with heart failure, expanding its cardiovascular portfolio and advancing its proprietary technology for heart rhythm therapy.

(more…)

View On WordPress

Y Combinator is Activly Recruiting Health-Tech Startups

Y Combinator is Activly Recruiting #HealthTech #Startups via @WhiteCItyNews

y-combinator-young-disciples

(Reuters) – What do Dropbox, Stripe, Airbnb and Reddit have in common? These technology firms all received mentorship and money from Silicon Valley’s so-called startup machine, Y Combinator.

Now, for the first time in its nine-year history, the accelerator program is actively recruiting health-technology startups. To attract top talent in healthcare and biotech, Y Combinator recently tapped…

View On WordPress

Chicago Innovation Exchange Is Accepting Member Applications

#Chicago Innovation Exchange Is Accepting Member Applications via @WhiteCityNews cc @ChicagoCIE

CIE-merged

The Chicago Innovation Exchange announced that they are accepting applications for both the Membership and Business Incubator programs.

Chicago Innovation Exchange Membership is for individual students, faculty, staff, and community members with passions for entrepreneurship and innovation, developing businesses, or looking to join an entrepreneurial team.

(more…)

View On WordPress

Chicago Medtech Company: ProofX is at the Forefront of Medical 3D Printing

#AdvaMed2014 Feature: @ProofXLabs is at the forefront of Medical #3DPrinting via @WhiteCityNews

Proofxhead

Occasionally a transformative technology comes along that catalyzes a new wave of innovation. The most transformative of which was the internet and the personal computer. Hoping to join that list is 3D printing.

(more…)

View On WordPress

Novartis CEO: Biosimilars Impact on Healthcare Still 3-5 Years Out

Novartis CEO: Biosimilar’s Impact on Healthcare Still 3-5 Years Out via @WhiteCityNews

Joe Jimenez, CEO of Swiss drugmaker Novartis gestures during an interview with Reuters at the company's headquarters in Basel March 19, 2014. Reuters/Arnd Wiegmann

(Reuters) – Swiss drugmaker Novartis AG does not expect copycat versions of biotech drugs to play an important role in the healthcare system for another three to five years, its chief executive said on Monday.

(more…)

View On WordPress